Vanguard Personalized Indexing Management
CL icon

Vanguard Personalized Indexing Management’s Colgate-Palmolive CL Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Buy
139,920
+15,357
+12% +$1.34M 0.11% 143
2026
Q1 		$10.6M Buy
124,563
+13,399
+12% +$1.19M 0.1% 164
2025
Q4 		$8.78M Buy
111,164
+20,013
+22% +$1.57M 0.09% 187
2025
Q3 		$7.29M Sell
91,151
-27,514
-23% -$2.35M 0.07% 222
2025
Q2 		$10.8M Buy
118,665
+17,956
+18% +$1.64M 0.12% 140
2025
Q1 		$9.44M Buy
100,709
+12,086
+14% +$1.08M 0.14% 122
2024
Q4 		$8.06M Buy
88,623
+392
+0.4% +$37.4K 0.12% 135
2024
Q3 		$9.16M Buy
88,231
+11,374
+15% +$1.16M 0.15% 116
2024
Q2 		$7.32M Buy
76,857
+14,811
+24% +$1.37M 0.14% 119
2024
Q1 		$5.59M Buy
62,046
+13,940
+29% +$1.18M 0.12% 152
2023
Q4 		$3.83M Buy
48,106
+13,930
+41% +$1.05M 0.1% 192
2023
Q3 		$2.43M Sell
34,176
-6,117
-15% -$457K 0.07% 262
2023
Q2 		$3.1M Buy
40,293
+4,327
+12% +$335K 0.1% 204
2023
Q1 		$2.7M Sell
35,966
-7,382
-17% -$549K 0.09% 218
2022
Q4 		$3.42M Sell
43,348
-11,632
-21% -$872K 0.14% 139
2022
Q3 		$3.86M Buy
54,980
+3,893
+8% +$305K 0.17% 106
2022
Q2 		$4.09M Buy
51,087
+23,816
+87% +$1.86M 0.19% 92
2022
Q1 		$2.07M Sell
27,271
-3,313
-11% -$262K 0.1% 184
2021
Q4 		$2.61M Buy
30,584
+19,961
+188% +$1.56M 0.15% 112
2021
Q3 		$803K Buy
10,623
+1,261
+13% +$100K 0.07% 295
2021
Q2 		$762K Buy
9,362
+11
+0.1% +$899 0.08% 309
2021
Q1 		$737K Buy
9,351
+336
+4% +$26.3K 0.11% 208
2020
Q4 		$771K Buy
9,015
+495
+6% +$40.9K 0.17% 133
2020
Q3 		$657K Buy
8,520
+2,837
+50% +$216K 0.18% 131
2020
Q2 		$416K Buy
5,683
+1,074
+23% +$76.3K 0.19% 134
2020
Q1 		$306K Buy
+4,609
New +$325K 0.18% 159

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Vanguard Personalized Indexing Management's CL Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Colgate-Palmolive (CL) stake by 12% in Q2 2026, buying an estimated $1.34M and bringing the position to 139,920 shares worth $12.8M. The position accounts for 0.11% of the portfolio, ranked #143.

Vanguard Personalized Indexing Management first reported a position in CL in Q1 2020 and has held it in 26 quarters since. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Vanguard Personalized Indexing Management held 139,920 shares of Colgate-Palmolive worth $12.8M as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 15,357 Colgate-Palmolive shares in Q2 2026, an estimated $1.34M.
  • Colgate-Palmolive made up 0.11% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #143 holding.
  • Vanguard Personalized Indexing Management first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 26 quarters since.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.